Want to see IN:DHANLAXMI full AI Analyst Report?
Top Page
Dhanlaxmi Crop Science Ltd.
(DHANLAXMI)
Select Model
Select Model
Rating:45Neutral
Price Target:―
Action:Reiterated
Date:09/06/26
The score is driven primarily by weakened financial performance: FY2026 profitability deteriorated sharply and multi-year negative operating/free cash flow increases near-term risk despite improved leverage. Valuation is also constrained by a negative P/E, while technical factors could not be evaluated from the provided indicators.
Positive Factors
Improved leverage
The sharp reduction in debt-to-equity materially lowers balance-sheet risk compared with FY2022 and should provide more flexibility to manage operations or fund opportunities. Moderate leverage is a durable financial cushion, even though weaker profitability reduces the benefit of that cushion.
Negative Factors
FY2026 earnings reversal
The latest-year deterioration weakens confidence in near-term earnings durability: revenue contracted after two years of strong growth, operating profitability compressed sharply, and net income became negative. Sustained losses could limit reinvestment capacity and make recovery dependent on improved execution.
Read all positive and negative factors
Positive Factors
Negative Factors
Improved leverage
The sharp reduction in debt-to-equity materially lowers balance-sheet risk compared with FY2022 and should provide more flexibility to manage operations or fund opportunities. Moderate leverage is a durable financial cushion, even though weaker profitability reduces the benefit of that cushion.
Read all positive factors
Dhanlaxmi Crop Science Ltd. (DHANLAXMI) vs. iShares MSCI India ETF (INDA)
Market Cap
N/A
Dividend YieldN/A
Average Volume (3M)N/A
Price to Earnings (P/E)―
Beta (1Y)N/A
Revenue GrowthN/A
EPS GrowthN/A
CountryIN
Employees47
SectorGeneral
Sector StrengthN/A
IndustryAgricultural Farm Products
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.71
Price to Book (P/B)0.82
Price to Sales (P/S)0.97
P/FCF Ratio-2.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Dhanlaxmi Crop Science Ltd. Business Overview & Revenue Model
Company Description
Dhanlaxmi Crop Science Ltd. is an Indian enterprise specializing in the manufacture and processing of agricultural seeds. Established in 1994 and based in Himatnagar, India, the company boasts a comprehensive portfolio of crop and vegetable seeds....
How the Company Makes Money
null...
Dhanlaxmi Crop Science Ltd. Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
64
Positive
Cash Flow
24
Negative
| Breakdown | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 381.29M | 1.29B | 637.10M | 466.11M | 354.31M |
| Gross Profit | 85.50M | 208.60M | 121.98M | 85.64M | 55.26M |
| EBITDA | 10.40M | 126.13M | 68.78M | 44.94M | 15.32M |
| Net Income | -4.92M | 86.80M | 46.78M | 29.95M | 5.83M |
Balance Sheet | |||||
| Total Assets | 638.44M | 829.16M | 349.62M | 200.27M | 208.63M |
| Cash, Cash Equivalents and Short-Term Investments | 14.03M | 138.89M | 10.99M | 32.27M | 14.38M |
| Total Debt | 105.82M | 71.72M | 10.42M | 25.83M | 91.32M |
| Total Liabilities | 183.97M | 369.78M | 188.41M | 86.31M | 146.91M |
| Stockholders Equity | 454.46M | 459.38M | 161.21M | 113.96M | 61.73M |
Cash Flow | |||||
| Free Cash Flow | -158.84M | -141.43M | -3.82M | 62.80M | 20.29M |
| Operating Cash Flow | -146.55M | -123.11M | 827.00K | 62.98M | 20.29M |
| Investing Cash Flow | -12.42M | -15.38M | -4.63M | -9.00K | 2.00K |
| Financing Cash Flow | 34.10M | 266.39M | -17.48M | -45.08M | -12.02M |
Dhanlaxmi Crop Science Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹68.02B | 15.89 | ― | ― | 21.04% | 59.07% | |
69 Neutral | ₹37.25B | 14.96 | ― | 1.39% | 1.46% | -22.35% | |
63 Neutral | ₹129.77B | 28.99 | ― | 1.64% | 8.58% | -1.86% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | ₹18.15B | 13.94 | ― | 0.33% | 1.26% | -16.43% | |
45 Neutral | ― | -78.67 | ― | ― | ― | ― |
* General Sector Average
IN:DHANLAXMI
Dhanlaxmi Crop Science Ltd.
―
―
―
IN:CONTI
Continental Seeds & Chemicals Ltd.
11.65
-16.40
-58.47%
IN:GODREJAGRO
Godrej Agrovet Limited
672.00
-48.99
-6.79%
IN:GOKULAGRO
Gokul Agro Resources Ltd.
226.45
47.37
26.45%
IN:INSECTICID
Insecticides (India) Limited
610.70
-171.90
-21.97%
IN:KSCL
Kaveri Seed Co. Ltd.
718.65
-432.61
-37.58%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.